Eli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Elected as a New Board Member
Accesswire
*STOCKHOLM, SWEDEN / ACCESSWIRE / May 15, 2024 /* AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB, a pharmaceutical..
*STOCKHOLM, SWEDEN / ACCESSWIRE / May 15, 2024 /* AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB, a pharmaceutical..
*STOCKHOLM, SWEDEN / ACCESSWIRE / April 10, 2024 /* AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB ("AlzeCure" or "the..
Poster presentation delivers pre-clinical results that demonstrate that its lead development product, Telomir-1, elongates telomere..